ACLS vs KLIC: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: KLIC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACLS and KLIC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACLS and KLIC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Axcelis Technologies designs and sells ion implantation equipment for the semiconductor industry, along with the aftermarket service and spare parts (its CS&I business) that keep those tools running. Ion implantation is the process step that shoots charged atoms into silicon wafers to change their electrical properties, and it is essential to making almost every chip. The company's Purion product family serves a wide range of end markets, including power devices (notably silicon carbide chips used in electric vehicles and industrial systems), image sensors, general mature-node logic, and memory such as DRAM and high-bandwidth memory (HBM). Ion implantation makes up the large majority of revenue, so Axcelis is a fairly pure play on that one process step rather than a diversified equipment giant.

Full ACLS guide

Kulicke & Soffa Industries (KLIC) designs and sells the capital equipment used to assemble and package finished semiconductors, most notably wire bonders that connect chips to their packages. The company is the clear leader in traditional wire bonding with an estimated global share above 60%, and it also sells wedge bonding, thermo-compression bonding, advanced-packaging tools, and consumables plus services to outsourced assembly and test houses (OSATs) and chipmakers. Its APTURA thermocompression platform targets leading-edge copper-to-copper and hybrid-bond-adjacent applications tied to AI logic and high-bandwidth memory.

Full KLIC guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACLS drivers: Memory recovery (DRAM and HBM); Power devices and silicon carbide.
• KLIC drivers: Assembly capex recovery; Wire-bonding dominance and installed base.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Axcelis is a small, highly cyclical company whose results swing with semiconductor capital-spending cycles it does not control, and its concentration in ion implantation means a slump in that step or in key end markets (like silicon carbide power chips) hits it hard, as the 2024 to 2025 revenue decline showed. For KLIC, revenue is deeply cyclical and concentrated in semiconductor assembly end-markets, so a stall in the current recovery could quickly compress earnings again.

Pick ACLS if you believe its drivers more; KLIC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACLS and KLIC guides.

ACLS. Axcelis revenue fell from about $1.02 billion in 2024 to roughly $839 million in 2025 as power and silicon carbide demand cooled, and net income compressed to around $120 million. With earnings down and the stock near $140, the trailing P/E of roughly 43x is elevated versus the company's own history, reflecting expectations for a memory-led recovery and the pending Veeco merger. All figures are approximate and change with each quarter and the market.

KLIC. The very high trailing P/E near 99 reflects earnings still depressed near a cyclical trough, while the much lower forward multiple around 25 assumes the recovery continues. The stock had risen sharply over the prior year on that expected upturn. A large cash balance and a dividend paid since 2018 provide downside support relative to smaller equipment peers.

Headline figures (approximate, JULY 2026): ACLS shows revenue (fy2025) ~$839 million, net income (fy2025) ~$120 million, revenue (ttm) ~$845 million, q1 2026 revenue ~$199 million (GAAP EPS ~$0.30); KLIC shows revenue (q2 fy2026) ~$243M (up ~50% YoY), revenue (fy2024) ~$712M, q3 fy2026 revenue guidance ~$310M, market cap ~$5.4B.

ACLS and KLIC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACLS and KLIC exposure against your real portfolio. It is not an investment adviser.